NHVMAS at a Glance
The New HIV Vaccine and Microbicide Advocacy Society (formerly Nigeria HIV Vaccine and Microbicides Advocacy Group-NHVMAG) was born out of a collective vision of a few Nigerian activists to ensure proactive and early involvement of the Nigerian Government and its citizens in New HIV Prevention Technology research and development.NHVMAS is a popularly owned campaign, with its members, supporters and partners as the driving force. It was established in 2003 as a broad movement of vaccine and microbicides advocates. It resulted from outcomes of collaborative meetings held around the drafting of Nigeria’s National Vaccine Plan in 2001/2002; Networking among advocates after microbicide conferences in USA (2001), Belgium (2002) and advocates meeting at Microbicides 2004 in London (25 Nigerian advocates in attendance). This resulted in the first National Advocates Meeting in Abuja in May 2004.
The New HIV Vaccine and Microbicide Advocacy Society was born out of a collective vision of a few Nigerian activists to ensure proactive and early involvement of the Nigerian Government and its citizens in New HIV Prevention Technology research and development.
A Nigeria where new biomedical HIV prevention and reproductive health tools are readily accessible to its citizens Strategic vision: A strengthened NHVMAS that is strategically position to address NPT and reproductive health related issues as defined in the national HIV/AIDS response.
The New HIV Vaccine and Microbicide Advocacy Society works with communities through its partner organisations and individuals to facilitate research literacy. Updating and information sharing is a key strategy of NHVMAS in achieve this goal. It therefore ensures all its members are enlisted on its mailing list for the NHVMAS ECHOES and subscription to its list-serve.
News and Insights
There is a strong need to grow a female condom usages campaign. Anecdotal evidence shows that large number of women who collect the female condoms during public health campaigns do not use it. They still defer to the use of male condoms – a tool that takes away...read more
ELISA cannot and should not be used to screen blood stored for transfusion. Any laboratory doing this should be charged with a crime against humanity. Elisa is only able to detect viral antibodies which is produced about 6-12 weeks after HIV infection. The PCR...read more
According to WHO adolescents are persons between 10-24yrs of age. This age is characterized by rapid physical growth and development as well as sexual maturation. Adolescents are also more risk-taking prone. This increases their risk of contracting HIV and other...read more